Medinotec (MDNC) Net Income towards Common Stockholders (2022 - 2026)
Medinotec's (MDNC) quarterly Net Income towards Common Stockholders came in at $208499.0 in Q2 2026, down 60.33% on a YoY basis from $525618.0 in Q2 2025, and up 144.68% quarter-over-quarter from -$466647.0 in Q1 2026.
Powered by 
Analysis
Medinotec (MDNC) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends
Medinotec (MDNC) has reported Net Income towards Common Stockholders for 5 consecutive years, with $208499.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Income towards Common Stockholders fell 60.33% year-over-year to $208499.0; the trailing twelve-month figure through May 2026 stood at $613931.0 (down 85.92% YoY), and the FY2026 full-year result was $1.5 million, down 62.25% from the prior year.
- Net Income towards Common Stockholders rose to $208499.0 in Q2 2026 per MDNC's latest filing, from -$466647.0 in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $3.2 million in Q1 2025 and bottomed at -$492371.0 in Q4 2023.
- Historically, Net Income towards Common Stockholders has averaged $248096.4 across 5 years, with a median of $54582.5 in 2022.
- The sharpest annual moves came in 2023 and 2024: Net Income towards Common Stockholders slumped 2342.02% in 2023, then soared 768.46% in 2024.
- Over 5 years, Net Income towards Common Stockholders stood at $21961.0 in 2022, then plunged by 2342.02% to -$492371.0 in 2023, then surged by 167.53% to $332486.0 in 2024, then jumped by 59.16% to $529199.0 in 2025, then tumbled by 60.6% to $208499.0 in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $208499.0, -$466647.0, and $529199.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 208,499.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 208,499.00 |
| Feb 28, 2026 | -466,647.00 |
| Nov 30, 2025 | 529,199.00 |
| Aug 31, 2025 | 342,880.00 |
| May 31, 2025 | 525,618.00 |
| Feb 28, 2025 | 3.21 Mn |
| Nov 30, 2024 | 332,486.00 |
| Aug 31, 2024 | 294,348.00 |
| May 31, 2024 | 87,204.00 |
| Feb 29, 2024 | 400,396.00 |
| Nov 30, 2023 | -492,371.00 |
| Aug 31, 2023 | -44,034.00 |
| May 31, 2023 | 18,350.00 |
| Feb 28, 2023 | -71,495.00 |
| Nov 30, 2022 | 21,961.00 |
| Aug 31, 2022 | -219,294.00 |
| May 31, 2022 | -83,904.00 |
| Feb 28, 2022 | -123,999.00 |